Priority of Japan Investment Lowered at 27% of Multinational Firms: JPMA Poll

Nearly 30% of multinational companies affiliated with three major research-driven pharma trade groups of Japan, the US, and Europe have lowered their priorities for Japan investments after 2016, an industry survey has revealed. The Japan Pharmaceutical Manufacturers Association (JPMA) conducted...read more